Erin Michelle Parry, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2023 | 1567 | 1.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 4 | 2023 | 1308 | 0.820 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 1732 | 0.600 |
Why?
|
| Telomere | 6 | 2016 | 829 | 0.590 |
Why?
|
| Dyskeratosis Congenita | 4 | 2013 | 74 | 0.570 |
Why?
|
| Telomerase | 5 | 2016 | 744 | 0.490 |
Why?
|
| Pulmonary Fibrosis | 3 | 2016 | 552 | 0.480 |
Why?
|
| DNA Repair | 1 | 2017 | 2061 | 0.320 |
Why?
|
| Hodgkin Disease | 2 | 2021 | 1441 | 0.240 |
Why?
|
| Adenocarcinoma | 4 | 2017 | 6370 | 0.240 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 3511 | 0.230 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 176 | 0.190 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 5988 | 0.180 |
Why?
|
| Mercury | 2 | 2012 | 238 | 0.170 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 1395 | 0.140 |
Why?
|
| Emphysema | 1 | 2016 | 220 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5152 | 0.130 |
Why?
|
| RNA | 2 | 2016 | 2748 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 17432 | 0.120 |
Why?
|
| Trout | 1 | 2012 | 15 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 12608 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2022 | 1932 | 0.110 |
Why?
|
| Barrett Esophagus | 3 | 2004 | 486 | 0.110 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2011 | 100 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 187 | 0.100 |
Why?
|
| Esophageal Neoplasms | 3 | 2004 | 1535 | 0.090 |
Why?
|
| Smoke | 1 | 2011 | 229 | 0.090 |
Why?
|
| Bone Marrow Diseases | 1 | 2011 | 236 | 0.090 |
Why?
|
| Anemia, Aplastic | 1 | 2011 | 235 | 0.090 |
Why?
|
| Heterozygote | 2 | 2013 | 2794 | 0.090 |
Why?
|
| Aeromonas salmonicida | 1 | 2008 | 5 | 0.090 |
Why?
|
| X Chromosome Inactivation | 1 | 2011 | 237 | 0.090 |
Why?
|
| R Factors | 1 | 2008 | 64 | 0.090 |
Why?
|
| Tobacco | 1 | 2011 | 418 | 0.080 |
Why?
|
| Conjugation, Genetic | 1 | 2008 | 154 | 0.080 |
Why?
|
| Ankyrins | 1 | 2007 | 124 | 0.080 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2007 | 151 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 824 | 0.070 |
Why?
|
| Pulmonary Emphysema | 1 | 2011 | 685 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2004 | 377 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2021 | 3274 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2011 | 2516 | 0.070 |
Why?
|
| Doxorubicin | 2 | 2022 | 2235 | 0.070 |
Why?
|
| Phenotype | 2 | 2013 | 16404 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2012 | 1101 | 0.060 |
Why?
|
| Age of Onset | 1 | 2011 | 3333 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11336 | 0.060 |
Why?
|
| Physicians | 1 | 2021 | 4354 | 0.060 |
Why?
|
| DNA Probes | 1 | 2004 | 556 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 599 | 0.060 |
Why?
|
| Mutation | 5 | 2021 | 29491 | 0.060 |
Why?
|
| Pedigree | 1 | 2011 | 4723 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 976 | 0.060 |
Why?
|
| Kerosene | 1 | 2001 | 16 | 0.060 |
Why?
|
| Humans | 20 | 2023 | 717280 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 7074 | 0.050 |
Why?
|
| Heating | 1 | 2001 | 88 | 0.050 |
Why?
|
| Bacteria | 1 | 2012 | 2098 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2004 | 2661 | 0.050 |
Why?
|
| Bleomycin | 1 | 2021 | 512 | 0.050 |
Why?
|
| Etoposide | 1 | 2022 | 630 | 0.050 |
Why?
|
| Vinblastine | 1 | 2021 | 509 | 0.050 |
Why?
|
| Vincristine | 1 | 2022 | 1043 | 0.050 |
Why?
|
| Cooking | 1 | 2001 | 337 | 0.050 |
Why?
|
| Dacarbazine | 1 | 2021 | 588 | 0.040 |
Why?
|
| Clone Cells | 1 | 2021 | 1760 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2007 | 2425 | 0.040 |
Why?
|
| Male | 11 | 2022 | 351399 | 0.040 |
Why?
|
| Prednisone | 1 | 2022 | 1548 | 0.040 |
Why?
|
| Neutropenia | 1 | 2022 | 880 | 0.040 |
Why?
|
| Adenine | 1 | 2022 | 929 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 2081 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2003 | 944 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 58528 | 0.040 |
Why?
|
| Middle Aged | 8 | 2022 | 215054 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 1826 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 2193 | 0.040 |
Why?
|
| Child | 3 | 2011 | 74388 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2023 | 4928 | 0.030 |
Why?
|
| Piperidines | 1 | 2022 | 1602 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2016 | 385 | 0.030 |
Why?
|
| Female | 10 | 2022 | 377934 | 0.030 |
Why?
|
| Adolescent | 3 | 2011 | 85143 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2001 | 1040 | 0.030 |
Why?
|
| Adult | 6 | 2017 | 212470 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1902 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2961 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 20572 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 2972 | 0.030 |
Why?
|
| Mice | 6 | 2023 | 81128 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1792 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2011 | 24744 | 0.030 |
Why?
|
| Aged | 6 | 2022 | 162862 | 0.030 |
Why?
|
| Leadership | 1 | 2021 | 1343 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2161 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 3016 | 0.030 |
Why?
|
| Animals | 8 | 2023 | 170894 | 0.030 |
Why?
|
| Infant | 2 | 2011 | 34574 | 0.030 |
Why?
|
| Aging | 1 | 2009 | 8376 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 7056 | 0.020 |
Why?
|
| Chromatin | 1 | 2021 | 2741 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 29226 | 0.020 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 276 | 0.020 |
Why?
|
| Edwardsiella | 1 | 2008 | 4 | 0.020 |
Why?
|
| Salmo salar | 1 | 2008 | 8 | 0.020 |
Why?
|
| Aeromonas hydrophila | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2289 | 0.020 |
Why?
|
| Integrons | 1 | 2008 | 22 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 841 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4266 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2008 | 204 | 0.020 |
Why?
|
| Gene Order | 1 | 2008 | 185 | 0.020 |
Why?
|
| Erythrocyte Deformability | 1 | 2007 | 57 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 1159 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20435 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 23997 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9532 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 1671 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2669 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 206 | 0.020 |
Why?
|
| Blood Group Antigens | 1 | 2007 | 172 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 757 | 0.020 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2011 | 436 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 2007 | 444 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 9927 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 22929 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5495 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 1532 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1211 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 56249 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2008 | 760 | 0.020 |
Why?
|
| Wales | 1 | 2003 | 85 | 0.020 |
Why?
|
| Glycine | 1 | 2007 | 699 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2004 | 204 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3698 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4935 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1428 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 137 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 8944 | 0.010 |
Why?
|
| Canada | 1 | 2008 | 1957 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2785 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4594 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 1526 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1551 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2007 | 1639 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2016 | 5135 | 0.010 |
Why?
|
| Chromosomes, Human, Y | 1 | 2003 | 148 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2008 | 1920 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 466 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2480 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 2470 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 14243 | 0.010 |
Why?
|
| Regional Health Planning | 1 | 1981 | 89 | 0.010 |
Why?
|
| Health Services Administration | 1 | 1981 | 63 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 15258 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 6133 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2003 | 480 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18738 | 0.010 |
Why?
|
| Ethiopia | 1 | 2001 | 472 | 0.010 |
Why?
|
| Allied Health Personnel | 1 | 1981 | 166 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2004 | 1270 | 0.010 |
Why?
|
| Eczema | 1 | 2001 | 206 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2007 | 4072 | 0.010 |
Why?
|
| Glucose | 1 | 2011 | 4303 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1097 | 0.010 |
Why?
|
| Binding Sites | 1 | 2007 | 6295 | 0.010 |
Why?
|
| Mitochondria | 1 | 2011 | 3642 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6860 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 4916 | 0.010 |
Why?
|
| Insulin | 1 | 2011 | 6691 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2008 | 4357 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 12923 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3993 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 4312 | 0.010 |
Why?
|
| Rhinitis | 1 | 2001 | 660 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 18798 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 72608 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5455 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 20654 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6529 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12435 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10376 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18353 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11777 | 0.010 |
Why?
|
| Risk | 1 | 2001 | 9773 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 14899 | 0.000 |
Why?
|
| Asthma | 1 | 2001 | 5941 | 0.000 |
Why?
|
| England | 1 | 1981 | 516 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2001 | 41221 | 0.000 |
Why?
|
| Efficiency | 1 | 1981 | 491 | 0.000 |
Why?
|